Mylan N.V. Sustainability Profile
Mylan N.V., a global leader in the pharmaceutical industry, is headquartered in Great Britain and operates extensively across North America, Europe, and Asia. Founded in 1961, Mylan has established itself as a key player in generic and specialty medications, focusing on providing high-quality, affordable healthcare solutions. The company is renowned for its extensive portfolio, which includes a wide range of generic drugs, complex generics, and over-the-counter products. Mylan's commitment to innovation and accessibility sets it apart in a competitive market, enabling it to serve millions of patients worldwide. With a strong market position, Mylan has achieved significant milestones, including strategic acquisitions that have expanded its global reach and product offerings. The company continues to prioritise patient needs, making it a trusted name in the pharmaceutical landscape.
DitchCarbon Score
How does Mylan N.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mylan N.V.'s score of 33 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mylan N.V., headquartered in Great Britain, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported figures. The company is a current subsidiary of Viatris Inc., which may influence its climate commitments and emissions reporting. As part of its corporate family relationship with Viatris Inc., Mylan N.V. inherits climate initiatives and targets from its parent company. However, there are no documented reduction targets or climate pledges specific to Mylan N.V. at this time. The absence of data suggests that Mylan N.V. may still be in the process of establishing its own distinct climate strategy or reporting framework. In the broader context, Viatris Inc. has been active in addressing climate change, and Mylan N.V. may align its efforts with the sustainability goals set by its parent company. This includes potential participation in initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which are cascaded from Viatris Inc. to Mylan N.V. at a corporate family level. Overall, while Mylan N.V. currently lacks specific emissions data and reduction targets, its affiliation with Viatris Inc. suggests a commitment to future climate action and sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 302,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 354,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Mylan N.V.'s Industry?
How Carbon Intensive is Mylan N.V.'s Location?
Mylan N.V.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Mylan N.V. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
